Innovative Cell Therapy in the Treatment of Serious Adverse Events Related to Both Chemo-Radiotherapy Protocol and Acute Myeloid Leukemia Syndrome: The Infusion of Mesenchymal Stem Cells Post-Treatment Reduces Hematopoietic Toxicity and Promotes Hematopoietic Reconstitution

Publisher: Bentham Science Publishers

E-ISSN: 1873-4316|14|9|842-848

ISSN: 1389-2010

Source: Current Pharmaceutical Biotechnology, Vol.14, Iss.9, 2013-10, pp. : 842-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract